INS and metabolic syndrome: It is thought that T2DM, as well as other metabolic syndromes, causes a central insulin resistance, which in turn leads to the disruption of insulin signaling pathways and as a consequence induces accelerated Aβ deposition and facilitates the polymerization of the tau protein, which is a possible mechanism that initiates dementia [5].